Development
e-therapeutics plc
ETXPF
OTC PK
07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 20.40% | 14.07% | 10.18% | 0.84% | -39.61% |
Total Receivables | 69.83% | 60.89% | 0.73% | -7.83% | -28.17% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 21.49% | 15.10% | 1.31% | -7.29% | 18.41% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 22.79% | 16.34% | -6.60% | -14.52% | 32.52% |
Total Current Assets | 21.02% | 14.65% | 9.08% | -0.17% | -35.73% |
|
|||||
Total Current Assets | 21.02% | 14.65% | 9.08% | -0.17% | -35.73% |
Net Property, Plant & Equipment | -70.01% | -71.59% | -54.40% | -58.26% | 629.54% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 74.89% | 65.60% | 115.05% | 96.78% | 80.88% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 19.20% | 12.93% | 7.72% | -1.42% | -33.97% |
|
|||||
Total Accounts Payable | 82.24% | 72.65% | 97.83% | 81.12% | -29.26% |
Total Accrued Expenses | -- | -- | -27.64% | -33.78% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -76.50% | -77.75% | -30.75% | -36.63% | -- |
Total Finance Division Other Current Liabilities | -- | -- | 304.40% | 270.43% | -- |
Total Other Current Liabilities | -- | -- | 304.40% | 270.43% | -- |
Total Current Liabilities | 23.41% | 16.92% | -1.95% | -10.27% | 12.38% |
|
|||||
Total Current Liabilities | 23.41% | 16.92% | -1.95% | -10.27% | 12.38% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 14.11% | 8.11% | -18.12% | -25.07% | 21.53% |
|
|||||
Common Stock & APIC | 19.96% | 13.65% | 4.14% | -4.69% | -12.48% |
Retained Earnings | -20.13% | -13.81% | -2.12% | 6.54% | 1.15% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 19.45% | 13.16% | 9.38% | 0.11% | -35.40% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 19.45% | 13.16% | 9.38% | 0.11% | -35.40% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 19.45% | 13.16% | 9.38% | 0.11% | -35.40% |
|